The number of precursor lesions informative for detailed analysis was limited, in keeping with the relative rarity of POLE mutations in endometrial cancer, and the frequency with which precancerous and cancerous lesions occur in the same tumour section. The gene discussed is POLE; the disease is endometrial cancer.